RE:RE:RE:RE:RE:Seen this all before with Kalytera. Option to aquire=0Dude51 wrote: What ever, go to Claritas investors site and read what the investor scientist said about CLAS. Then come back and tell us what you think. Seeing the non news again today affirms my belief this stock is BS.
I looked at the articles you reference, they are 10 to 15 years old. I would think the technology and science on this has changed somewhat in tha time, would it not?
You also pulled this quote out on that site,
"a recent meta-analysis of 16 clinical trials of prostacyclin analogs, endothelin receptor antagonists, and phosphodiesterase type 5 inhibitors in severe pulmonary arterial hypertension (PAH) from 1990 to 2005 shows that although the pharmacological agents moderately improve symptoms and hemodynamic parameters, none significantly reduces mortality (13). These disappointing results are not predicted by animal model studies, which show these classes of drugs largely prevent, and in some cases reverse, chronic hypoxia- and monocrotaline-induced pulmonary hypertension in rats (e.g., 6, 25, 29, 30). " With the many advances in the medical and scientific field I don't thing we can consider research from 1990 to 2005 recent.
To save people the trouble of searching here are the links.
https://journals.physiology.org/doi/full/10.1152/ajplung.00281.2007
https://www.atsjournals.org/doi/full/10.1164/rccm.200502-296OC
https://erj.ersjournals.com/content/37/4/813.short